α-D-Glucose-1-phosphate disodium salt tetrahydrate, 10g, >=98%

(1R,2R,5R)-(+)-2-Hydroxy-3-pinanone>98.0%(GC)5g

2-(2,4-DIFLUOROPHENYL)-1-(PYRIDIN-3-YL)ETHAN-1-ONE, 95.0%, 500mg

4-Methylphthalic Anhydride>98.0%(GC)(T)500g

Microliter syringe GASTIGHT® series 1700 Point type 2, 250 µl, 1725 RN, 1 piece

4-BROMO-6-FLUOROQUINOLINE, 95.0%, 1g

N-(5-IODO-PYRIDIN-2-YL)-4-METHYL-BENZENESULFONAMIDE, 95.0%, 2g

3-[(4-fluorophenyl)sulfonyl]azetidine hydrochloride, 95.0%, 250mg

5-Bromo-2-methylisoindolin-1-one, 95.0%, 5g

5-Bromo-2-chloro-N-methoxy-N-methylisonicotinamide, 98%, 250mg

2,6-Difluoro-3-methylbenzonitrile, 5g

2-Phenylethanamine hydrochloride, 95.0%, 1kg

2-Amino-4-(methylthio)butan-1-ol, 95.0%, 1g